A Study to Collect Blood Samples from Pediatric Patients (0 months -18 years) with a Suspected or Confirmed Primary Immunodeficiency for the Creation of a PID Sample Bank or from Healthy Children (0 months - 18 years)

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Scottsdale/Phoenix, Arizona: 1942-05
    • Rochester, Minnesota: 1942-05
    Sponsor Protocol Number: 1942-05

About this study

This study is being done to obtain blood samples and fibroblasts samples (if already being collected for clinical purposes) for clinical and laboratory studies of Primary Immunodeficiencies (PID), which include several different disorders of the immune system and/or its function in the body. This study will help us to better understand these disorders of the immune system and allow us to improve our ability to diagnose and treat these diseases more efficiently and quickly.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Pediatric individuals seen in the Pediatric Immunodeficiency clinic for evaluation of primary immunodeficiencies (PIDs). 
  • Patients with a confirmed diagnosis of PIDs 
  • Pediatric individuals who are confirmed as not having a primary immunodeficiency or any immunological anomaly will be consented as a healthy participant for inclusion in the Reference Range Sample Bank.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Roshini Abraham, Ph.D.

Contact us for the latest status

Contact information:

Matthew Rank M.D.

(480)342-4200

Rank.Matthew@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Roshini Abraham, Ph.D.

Open for enrollment

Contact information:

Brittany Price

(507)266-8725

Price.Brittany@mayo.edu

.
CLS-20317349

Mayo Clinic Footer